Penserra Capital Management LLC Theravance Biopharma, Inc. Transaction History

Penserra Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$7.42 - $11.05 $12,502 - $18,619	-1,685 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$6.77 - $14.41 $1,354 - $2,882	200 Added 13.47%	1,685 $12,000
Q2 2021 Aug 12, 2021	BUY	$14.52 - $22.46 $363 - $561	25 Added 1.71%	1,485 $21,000
Q1 2021 May 13, 2021	SELL	$16.57 - $21.08 $82 - $105	-5 Reduced 0.34%	1,460 $29,000
Q4 2020 Feb 12, 2021	BUY	$14.89 - $20.16 $13,743 - $18,607	923 Added 170.3%	1,465 $26,000
Q3 2020 Nov 13, 2020	BUY	$14.79 - $22.49 $8,016 - $12,189	542 New	542 $8,000

129

46.5M

600

300

Ticker TBPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,782,400
Market Cap $622M
Description
Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also inc...

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Penserra Capital Management LLC with notifications on news.